Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function (EMPROVE)
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
Sponsor: Olympus Corporation of the Americas
This NA trial investigates Emphysema and is currently completed. Olympus Corporation of the Americas leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2024 — Jul 2024 [monthly]
Completed NA
-
Oct 2023 — Jun 2024 [monthly]
Completed NA
-
Apr 2023 — Oct 2023 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 9 earlier versions
-
Jun 2022 — Apr 2023 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Jun 2022 [monthly]
Active Not Recruiting NA
-
May 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Olympus Corporation of the Americas
For direct contact, visit the study record on ClinicalTrials.gov .